Teladoc Health (NYSE:TDOC) Shares Gap Up - Time to Buy?

Key Points

• Teladoc Health shares gapped up ahead of Thursday’s trading, opening at $6.97 after closing at $6.59, with the stock last trading near $6.99 on moderate volume.
• Recent analyst actions were mostly cautious: several firms cut price targets, and the overall consensus rating is Hold with an average price target of $7.43.
• The company’s latest quarter showed a slight EPS miss and declining revenue, while its CEO also sold shares; despite that, institutional ownership remains high at 76.82%.

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report)'s share price gapped up prior to trading on Thursday . The stock had previously closed at $6.59, but opened at $6.97. Teladoc Health shares last traded at $6.9880, with a volume of 870,828 shares.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on TDOC. Oppenheimer reduced their price target on shares of Teladoc Health from $12.00 to $7.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 3rd. Canaccord Genuity Group reduced their price target on shares of Teladoc Health from $12.00 to $10.00 and set a "buy" rating on the stock in a research report on Thursday, February 26th. TD Cowen reduced their price target on shares of Teladoc Health from $8.00 to $6.00 and set a "hold" rating on the stock in a research report on Thursday, February 26th. Piper Sandler restated an "overweight" rating and issued a $9.00 price target (down from $12.00) on shares of Teladoc Health in a research report on Thursday, February 26th. Finally, Wells Fargo & Company reduced their price target on shares of Teladoc Health from $8.00 to $6.00 and set an "equal weight" rating on the stock in a research report on Thursday, February 26th. Five equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $7.43.

Teladoc Health Stock Performance

The stock has a market capitalization of $1.26 billion, a P/E ratio of -7.23 and a beta of 2.08. The company's 50-day moving average is $5.92 and its two-hundred day moving average is $6.21. The company has a current ratio of 2.80, a quick ratio of 2.72 and a debt-to-equity ratio of 0.75.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.01). The firm had revenue of $613.85 million during the quarter, compared to the consensus estimate of $611.04 million. Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The company's revenue for the quarter was down 2.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.53) earnings per share. Teladoc Health has set its FY 2026 guidance at -1.050--0.750 EPS and its Q2 2026 guidance at -0.300--0.200 EPS. As a group, sell-side analysts anticipate that Teladoc Health, Inc. will post -0.91 EPS for the current fiscal year.

Insider Activity

In other news, CEO Charles Divita III sold 27,731 shares of Teladoc Health stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $5.49, for a total value of $152,243.19. Following the transaction, the chief executive officer owned 364,784 shares of the company's stock, valued at $2,002,664.16. The trade was a 7.06% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 0.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Teladoc Health

Several hedge funds have recently made changes to their positions in the business. Federated Hermes Inc. grew its stake in shares of Teladoc Health by 0.5% in the 3rd quarter. Federated Hermes Inc. now owns 307,700 shares of the health services provider's stock worth $2,379,000 after purchasing an additional 1,450 shares during the last quarter. Creative Planning grew its stake in shares of Teladoc Health by 7.7% in the 3rd quarter. Creative Planning now owns 20,567 shares of the health services provider's stock worth $159,000 after purchasing an additional 1,462 shares during the last quarter. Krane Funds Advisors LLC grew its stake in shares of Teladoc Health by 13.4% in the 3rd quarter. Krane Funds Advisors LLC now owns 12,431 shares of the health services provider's stock worth $106,000 after purchasing an additional 1,469 shares during the last quarter. State of Wyoming grew its stake in shares of Teladoc Health by 2.1% in the 3rd quarter. State of Wyoming now owns 79,075 shares of the health services provider's stock worth $611,000 after purchasing an additional 1,628 shares during the last quarter. Finally, Syon Capital LLC grew its stake in shares of Teladoc Health by 19.1% in the 4th quarter. Syon Capital LLC now owns 14,140 shares of the health services provider's stock worth $99,000 after purchasing an additional 2,264 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc's service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.